Insulin action and insulin secretion in identical twins with MODY. Evidence for defects in both insulin action and secretion
- PMID: 3289993
- DOI: 10.2337/diab.37.6.730
Insulin action and insulin secretion in identical twins with MODY. Evidence for defects in both insulin action and secretion
Abstract
To evaluate the pathogenetic mechanisms responsible for development of diabetes in the genetically inherited disease maturity-onset diabetes of the young (MODY), we have investigated a pair of identical twins (19 yr old) from a MODY family. One twin had nondiabetic fasting plasma glucose values but impaired glucose tolerance (IGT), whereas the other suffered from frank diabetes (fasting plasma glucose 12.5 mM). Differences in insulin secretion pattern and/or insulin action between the twins is supposed to be responsible for development of hyperglycemia in MODY. On the other hand, identical defects in insulin secretion and action in the twins may point to the primary genetic defect in MODY. Therefore, our aim was to investigate insulin secretion and insulin action in the twins to find these differences and similarities. We found that fasting plasma insulin and C-peptide values were slightly increased in the twins, whereas the responses of insulin and C-peptide to oral glucose tolerance tests (OGTT) and meals were similar in the twins and within normal range. The insulin responses to OGTT were, however, lower than expected from the glucose values, indicating a beta-cell defect. Despite elevated plasma insulin levels, basal hepatic glucose output (HGO) was normal in the IGT twin but increased by 75% in the diabetic twin. The maximally inhibitory effect of insulin on HGO, when estimated at euglycemia, was normal in the IGT twin but reduced by 60% in the diabetic twin. Furthermore, the maximal insulin-mediated glucose uptake in peripheral tissues was reduced by 40% in the diabetic twin.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.J Clin Invest. 1995 Feb;95(2):690-8. doi: 10.1172/JCI117715. J Clin Invest. 1995. PMID: 7860750 Free PMC article. Clinical Trial.
-
Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree.Diabetes. 1994 Jan;43(1):40-6. doi: 10.2337/diab.43.1.40. Diabetes. 1994. PMID: 8262315
-
Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.Diabetologia. 2000 Dec;43(12):1476-83. doi: 10.1007/s001250051558. Diabetologia. 2000. PMID: 11151756
-
Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.Dan Med J. 2014 Jul;61(7):B4890. Dan Med J. 2014. PMID: 25123125 Review.
-
On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights.Dan Med Bull. 1999 Jun;46(3):197-234. Dan Med Bull. 1999. PMID: 10421979 Review.
Cited by
-
Assessment of insulin sensitivity in glucokinase-deficient subjects.Diabetologia. 1996 Jan;39(1):82-90. doi: 10.1007/BF00400417. Diabetologia. 1996. PMID: 8720607
-
O-Linked β-N-acetylglucosamine (O-GlcNAc) Acts as a Glucose Sensor to Epigenetically Regulate the Insulin Gene in Pancreatic Beta Cells.J Biol Chem. 2016 Jan 29;291(5):2107-18. doi: 10.1074/jbc.M115.693580. Epub 2015 Nov 23. J Biol Chem. 2016. PMID: 26598517 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical